Gansad, Mary Jane .
HRN: 25-30-16 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/20/2024
CEFTRIAXONE 1G (VIAL)
06/20/2024
06/27/2024
IVTT
2G
OD
TYPHOID FEVER
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes